Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients

doi:10.4239/wjd.v15.i6.1178

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8273)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

102

HTML

6346

Figures (1-2)

102

Tables (1-2)

102

Sum=6652

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

112

Sum=130

Jun 15, 2024 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Jun 15, 2024; 15(6): 1178-1186
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1178

Open in New Tab Full Size Figure Download Figure

Figure 1 Pathophysiology of metformin-associated lactic acidosis. ¹Metformin is eliminated unchanged by the kidney.

Open in New Tab Full Size Figure Download Figure

Figure 2 Diagnosis and management of metformin-associated lactic acidosis. HCO₃: Serum bicarbonate concentration; PaCO₂: Arterial partial pressure of carbon dioxide; VA-ECMO: Venoarterial extracorporeal membrane oxygenation.

Citation: See KC. Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients. World J Diabetes 2024; 15(6): 1178-1186
URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1178.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1178